PPFIBP2 and cholangiocarcinoma: CCA cell lines with high ACSL3 expression (KKU-213B and RMCCA-1) showed greater resistance to RSL3 compared to the CCA cell lines with low ACSL3 expression (CCLP-1 and RBE) (Fig. 2c, d).